Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Recent patents describe novel analgesic agents

Feb. 2, 2006

IND for ADL-5859 placed on hold

Feb. 1, 2006

NDA for NRP-104 accepted for review

Feb. 1, 2006

PTC-124 studied in new phase II trial for Duchenne muscular dystrophy

Feb. 1, 2006

Labopharm's once-daily tramadol NDA accepted for review

Feb. 1, 2006

Caspase inhibition may lower the risk of AD post-TBI

Feb. 1, 2006

New compound targets glia and modulates progression of AD

Feb. 1, 2006

European approval for Ionsys in postoperative pain

Jan. 31, 2006

European CHMP hands down positive opinion for Lyrica in GAD

Jan. 31, 2006

Avanir submits expanded Neurodex NDA

Jan. 31, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...